Automated real-time monitoring of human pluripotent stem cell aggregation in stirred tank reactors

[1]  Christoph Bock,et al.  Assessment of established techniques to determine developmental and malignant potential of human pluripotent stem cells , 2018, Nature Communications.

[2]  Antoine Heron,et al.  Scalable stirred suspension culture for the generation of billions of human induced pluripotent stem cells using single‐use bioreactors , 2018, Journal of tissue engineering and regenerative medicine.

[3]  The Initiative Assessment of established techniques to determine developmental and malignant potential of human pluripotent stem cells , 2018 .

[4]  Yasuyuki Sakai,et al.  Effects of glucose, lactate and basic FGF as limiting factors on the expansion of human induced pluripotent stem cells. , 2018, Journal of bioscience and bioengineering.

[5]  Jan Hansmann,et al.  Hypoxic Three-Dimensional Scaffold-Free Aggregate Cultivation of Mesenchymal Stem Cells in a Stirred Tank Reactor , 2017, Bioengineering.

[6]  M. Goumans,et al.  Defined Engineered Human Myocardium With Advanced Maturation for Applications in Heart Failure Modeling and Repair , 2017, Circulation.

[7]  J. C. Belmonte,et al.  Ground rules of the pluripotency gene regulatory network , 2017, Nature Reviews Genetics.

[8]  Robert Zweigerdt,et al.  Impact of Feeding Strategies on the Scalable Expansion of Human Pluripotent Stem Cells in Single‐Use Stirred Tank Bioreactors , 2016, Stem cells translational medicine.

[9]  Todd C McDevitt,et al.  Aggregate formation and suspension culture of human pluripotent stem cells and differentiated progeny. , 2016, Methods.

[10]  Julia B. Guidry,et al.  Cytoskeletal Expression and Remodeling in Pluripotent Stem Cells , 2016, PloS one.

[11]  Jan Hansmann,et al.  Evaluation of various bioreactor process systems for the production of induced pluripotent stem cells , 2016 .

[12]  Robert Zweigerdt,et al.  Cardiac differentiation of human pluripotent stem cells in scalable suspension culture , 2015, Nature Protocols.

[13]  Maria Sundberg,et al.  Successful function of autologous iPSC-derived dopamine neurons following transplantation in a non-human primate model of Parkinson's disease. , 2015, Cell stem cell.

[14]  D. Melton,et al.  Generation of Functional Human Pancreatic β Cells In Vitro , 2014, Cell.

[15]  S. Reuveny,et al.  An intermittent rocking platform for integrated expansion and differentiation of human pluripotent stem cells to cardiomyocytes in suspended microcarrier cultures. , 2014, Stem cell research.

[16]  Jincheng Wu,et al.  Oxygen Transport and Stem Cell Aggregation in Stirred-Suspension Bioreactor Cultures , 2014, PloS one.

[17]  N. Nakatsuji,et al.  A 3D Sphere Culture System Containing Functional Polymers for Large-Scale Human Pluripotent Stem Cell Production , 2014, Stem cell reports.

[18]  N. Nakatsuji,et al.  A 3D Sphere Culture System Containing Functional Polymers for Large-Scale Human Pluripotent Stem Cell Production , 2014, Stem cell reports.

[19]  Yan Li,et al.  Stem cell engineering in bioreactors for large‐scale bioprocessing , 2014 .

[20]  Andreas Fouras,et al.  Optimization of agitation speed in spinner flask for microcarrier structural integrity and expansion of induced pluripotent stem cells , 2014, Cytotechnology.

[21]  S. Gerecht,et al.  Scalable expansion of human induced pluripotent stem cells in the defined xeno-free E8 medium under adherent and suspension culture conditions. , 2013, Stem cell research.

[22]  Mohammad Wahid Ansari,et al.  The legal status of in vitro embryos , 2014 .

[23]  R. P. Wolfe,et al.  Effects of shear stress on germ lineage specification of embryonic stem cells. , 2012, Integrative biology : quantitative biosciences from nano to macro.

[24]  Catarina Brito,et al.  Process engineering of human pluripotent stem cells for clinical application. , 2012, Trends in biotechnology.

[25]  Robert Zweigerdt,et al.  Suspension culture of human pluripotent stem cells in controlled, stirred bioreactors. , 2012, Tissue engineering. Part C, Methods.

[26]  S. Schwartz,et al.  Embryonic stem cell trials for macular degeneration: a preliminary report , 2012, The Lancet.

[27]  Dongrui Ma,et al.  Clinical applications of patient-specific induced pluripotent stem cells in cardiovascular medicine , 2012, Heart.

[28]  G. Daley,et al.  The promise of induced pluripotent stem cells in research and therapy , 2012, Nature.

[29]  B. Strulovici,et al.  Induced pluripotent stem cells — opportunities for disease modelling and drug discovery , 2011, Nature Reviews Drug Discovery.

[30]  Wei-Shou Hu,et al.  Stem cell culture engineering – process scale up and beyond , 2011, Biotechnology journal.

[31]  Robert A Watson,et al.  What is the potential of oligodendrocyte progenitor cells to successfully treat human spinal cord injury? , 2011, BMC neurology.

[32]  Katriina Aalto-Setälä,et al.  Cardiac Differentiation of Pluripotent Stem Cells , 2011, Stem cells international.

[33]  Bernhard M. Schuldt,et al.  A bioinformatic assay for pluripotency in human cells , 2011, Nature Methods.

[34]  J. Itskovitz‐Eldor,et al.  Suspension Culture of Undifferentiated Human Embryonic and Induced Pluripotent Stem Cells , 2010, Stem Cell Reviews and Reports.

[35]  Sean J Morrison,et al.  Mechanisms of stem cell self-renewal. , 2009, Annual review of cell and developmental biology.

[36]  Stefan Wagner,et al.  Generation of induced pluripotent stem cells from human cord blood. , 2009, Cell stem cell.

[37]  Robert Passier,et al.  Cardiomyocytes from human pluripotent stem cells in regenerative medicine and drug discovery. , 2009, Trends in pharmacological sciences.

[38]  Emmanuel S. Tzanakakis,et al.  Stem cells for heart cell therapies. , 2008, Tissue engineering. Part B, Reviews.

[39]  L. Lock,et al.  Stem/Progenitor cell sources of insulin-producing cells for the treatment of diabetes. , 2007, Tissue engineering.

[40]  X. Zeng,et al.  Human embryonic stem cells: Long term stability, absence of senescence and a potential cell source for neural replacement , 2007, Neuroscience.

[41]  Lil Pabon,et al.  Regeneration gaps: observations on stem cells and cardiac repair. , 2006, Journal of the American College of Cardiology.

[42]  Robert Zweigerdt,et al.  Differentiation and lineage selection of mouse embryonic stem cells in a stirred bench scale bioreactor with automated process control. , 2005, Biotechnology and bioengineering.

[43]  D K Robinson,et al.  Industrial choices for protein production by large-scale cell culture. , 2001, Current opinion in biotechnology.

[44]  M. Sherman,et al.  A Preliminary Report , 1953 .